Patents Assigned to E2BIO LIFE SCIENCES, LLC
  • Patent number: 11633352
    Abstract: An oral gel composition suitable for the treatment of oral leukoplakia comprising a combination of diclofenac with hyaluronic acid and methods of administering the oral gel that may include a device that prolongs contact time of the oral gel with the areas of the mucosa that are affected by oral leukoplakia.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: April 25, 2023
    Assignee: E2Bio Life Science, LLC
    Inventor: Eli D. Ehrenpreis
  • Publication number: 20220354629
    Abstract: A method of enhancing absorption of a therapeutic agent sublingually in a person configured to treat chronic graft-versus-host disease (cGVHD) or aphthous stomatitis. The method includes administering a therapeutically effective amount of the therapeutic agent sublingually in a person and then inserting for a predetermined treatment period a device in an oral cavity of the person, wherein the device comprising an oral retention portion that is configured to be retained in the oral cavity from the predetermined treatment period and further configured to enhance absorption of the therapeutic agent sublingually.
    Type: Application
    Filed: July 20, 2022
    Publication date: November 10, 2022
    Applicant: E2BIO LIFE SCIENCES, LLC
    Inventor: Eli D. Ehrenpreis
  • Publication number: 20220023022
    Abstract: A method of enhancing absorption of a therapeutic agent sublingually in a person. The method includes administering a therapeutically effective amount of the therapeutic agent sublingually in a person and then inserting for a predetermined treatment period a device in an oral cavity of the person, wherein the device comprising an oral retention portion that is configured to be retained in the oral cavity from the predetermined treatment period and further configured to enhance absorption of the therapeutic agent sublingually.
    Type: Application
    Filed: October 12, 2021
    Publication date: January 27, 2022
    Applicant: E2BIO LIFE SCIENCES, LLC
    Inventor: Eli D. Ehrenpreis
  • Patent number: 11229578
    Abstract: A method and device for the prevention and treatment of oral mucositis using a combination of an anti-mucositis agent and the device that is held in place for prolonged periods of time within the mouth. Portions of the device overlie and are brought into direct contact with the portions of the oral mucosa that are affected by oral mucositis. The method provides prolonged contact time of the anti-mucositis agents to the areas of the mucosa that are affected by oral mucositis. The combination may be used to treat oral mucositis or, prophylactically, to prevent oral mucositis that may occur in patients that receive chemotherapy and/or radiation therapy.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: January 25, 2022
    Assignee: E2BIO LIFE SCIENCES, LLC
    Inventor: Eli D. Ehrenpreis